Skip to main content
SpringerLink
Log in

Resistant Mutants of Staphylococcus aureus with Ofloxacin in Comparison with Ciprofloxacin

  • Poster Presentations
  • Extended Abstract
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Carsenti-Etesse H, Bernard E, Bensoussan F, et al. Induction of resistance in vitro of Streptococcus pneumoniae to pefloxacin, ofloxacin, ciprofloxacin, sparfloxacin, temafloxacin [abstract 1047]. 33th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1993 Oct 17–20; New Orleans

  2. Forstall GJ, Knapp CC, Washington JA. Activity of new quinolones against ciprofloxacin-resistant staphylococci. Antimicrob Agents Chemother 1991; 35: 1679–81

    Article  PubMed  CAS  Google Scholar 

  3. Kaatz GW, Seo SM, Barriere SL, et al. Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 1990; 34: 257–60

    Article  PubMed  CAS  Google Scholar 

  4. Kaatz GW, Barriere SL, Schaberg DR, et al. The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis. J Antimicrob Chemother 1987; 20: 753–8

    Article  PubMed  CAS  Google Scholar 

  5. Kang SL, Rybak MJ, McGrath BJ, et al. Pharmacodynamics of levofloxacin, ofloxacin and ciprofloxacin alone and in combination with rifampicin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model. Antimicrob Agents Chemother 1994; 38: 2702–9

    Article  PubMed  CAS  Google Scholar 

  6. Kitzis MD, Gutmann L, Acar JF, et al. Selection of one step-resistant mutants of Streptococcus pneumoniae with grepafloxacin in comparison to other fluoroquinolones [abstract 10824]. 8th International Congress on Infectious Diseases; 1998 May 18–20; Boston

  7. Thomson KS, Moland ES, Sanders CC. Comparison of potential of trovafloxacin, ofloxacin and ciprofloxacin to select less susceptible mutants in vitro [abstract C-86]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997 Sep 28–Oct 1; Toronto

  8. Sulavik MC, Peshick S, Barg NL. Ciprofloxacin selects low level quinolone-resistant mutants of methicillin-resistant and —susceptible Staphylococcus aureus more frequently than ofloxacin or levofloxacin in vitro and in vivo [abstract C113]. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996 Sep 15–18; New Orleans

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Bactériologie, Hôpital N-D De Bon Secours, CHR Metz-Thionville, 20, rue Drogon, 57000, Metz, France

    Y. Rio, F. Jurin & J. Didion

Authors
  1. Y. Rio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Jurin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Didion
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rio, Y., Jurin, F. & Didion, J. Resistant Mutants of Staphylococcus aureus with Ofloxacin in Comparison with Ciprofloxacin. Drugs 58 (Suppl 2), 130–131 (1999). https://doi.org/10.2165/00003495-199958002-00031

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199958002-00031

Search

Navigation